# BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

Source: https://onco.cc/trials/nct07629609/  
OnCo record `nct07629609` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in pancreatic cancer, run by Barbara Malene Fischer, now recruiting.

## Summary

BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer is a phase 2, interventional study registered as NCT07629609 by Barbara Malene Fischer, with a registry enrolment figure of 90 participants, started 2024-01-16 and due to reach its primary completion in 2027-01. Interventions recorded: [68Ga]Ga-FAPI-46. Conditions listed: Pancreatic Cancer, Adult; Gastroesophageal Cancer (GC). Primary outcome: Sensitivity of [68Ga]Ga-FAPI-46 Total Body PET/CT. Pancreatic eligibility wording from the registry: "Patients with suspected pancreatic cancer based on morphological findings on standard imaging". Sites: Denmark. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: BEFAST
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07629609
- Phase: 2
- Setting: [68Ga]Ga-FAPI Total Body PET/CT for Improving Diagnostic Sensitivity and Preoperative Staging in Gastroesophageal Cancer and Pancreatic Cancer
- Sponsor: Barbara Malene Fischer
- Enrolled: 90

## Sources

- ClinicalTrials.gov NCT07629609: https://clinicaltrials.gov/study/NCT07629609

## Connected records

- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07629609.json